| Symbol | INSP |
|---|---|
| Name | INSPIRE MEDICAL SYSTEMS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 5500 WAYZATA BLVD.,SUITE 1600, GOLDEN VALLEY, Minnesota, 55416, United States |
| Telephone | +1 844 672 - 4357 |
| Fax | — |
| — | |
| Website | https://www.inspiresleep.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001609550 |
| Description | Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. Additional info from NASDAQ: |
2026-05-15 20:17
📋 JOHN RONDONI (Officer) plans to sell 3K shares of INSPIRE MEDICAL SYSTEMS, INC. (at $43.28 each, total $114K) Filed: May 15, 2026 | ID: 004597
Read more
2026-05-15 20:05
Rondoni John 🔴 sold 700 shares of Inspire Medical Systems, Inc. (INSP) at $43.01 Transaction Date: May 14, 2026 | Filing ID: 062498
Read more
2026-05-14 21:22
New Form SCHEDULE 13G/A - Inspire Medical Systems, Inc. <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0001193805-26-000612 <b>Size:</b> 17 KB
Read more
2026-05-14 20:34
📋 JOHN RONDONI (Officer) plans to sell 700 shares of INSPIRE MEDICAL SYSTEMS, INC. (at $43.01 each, total $30K) Filed: May 14, 2026 | ID: 004540
Read more
2026-05-11 20:05
Director mcCormick Shawn 🔴 sold 696 shares of Inspire Medical Systems, Inc. (INSP) at $45.31 Transaction Date: May 08, 2026 | Filing ID: 058634
Read more
2026-05-08 20:22
📋 SHAWN T MCCORMICK (Director) plans to sell 696 shares of INSPIRE MEDICAL SYSTEMS, INC. (at $45.57 each, total $32K) Filed: May 08, 2026 | ID: 004261
Read more
2026-05-07 13:15
New Form S-8 - Inspire Medical Systems, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001609550-26-000030 <b>Size:</b> 619 KB
Read more
2026-05-04 22:28
Director Ellis Gary Lee 🟢 acquired 3.6K shares of Inspire Medical Systems, Inc. (INSP) Transaction Date: Apr 30, 2026 | Filing ID: 055066
Read more
2026-05-04 22:27
Director Mead Dana G Jr. 🟢 acquired 3.6K shares of Inspire Medical Systems, Inc. (INSP) Transaction Date: Apr 30, 2026 | Filing ID: 055065
Read more
2026-05-04 22:24
Director Tansey Casey M 🟢 acquired 3.6K shares of Inspire Medical Systems, Inc. (INSP) Transaction Date: Apr 30, 2026 | Filing ID: 055064
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07277296 | CGUARDIANS III IDE Pivotal Trial | Na | Carotid Artery Stenosis | Not_Yet_Recruiting | 2026-01-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07116395 | Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma | Phase4 | Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System | Not_Yet_Recruiting | 2026-01-01 | 2030-12-31 | ClinicalTrials.gov |
| NCT07113288 | Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-App… | — | Obstructive Sleep Apnea (OSA) | Recruiting | 2025-07-31 | 2032-01-01 | ClinicalTrials.gov |
| NCT07304778 | Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing an… | Na | Diabetes (Insulin-requiring, Type 1 or Type 2) | Recruiting | 2025-07-11 | 2026-06-01 | ClinicalTrials.gov |
| NCT06971796 | EURO-STIM Registry | — | Obstructive Sleep Apnea | Recruiting | 2025-05-26 | 2035-04-01 | ClinicalTrials.gov |
| NCT06851338 | Pediatric Down Syndrome Post-Approval Study | Na | Pediatric Obstructive Sleep Apnea | Recruiting | 2025-02-01 | 2030-05-01 | ClinicalTrials.gov |
| NCT05967195 | Trial to Increase FEP Attendance | Early_Phase1 | First-Episode Psychosis | Active_Not_Recruiting | 2025-02-01 | 2026-07-31 | ClinicalTrials.gov |
| NCT06653387 | A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of t… | Na | Carotid Artery Diseases | Recruiting | 2024-11-20 | 2027-11-20 | ClinicalTrials.gov |
| NCT06540716 | Inspire Singapore Study | Na | Obstructive Sleep Apnea | Recruiting | 2024-08-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT06339125 | Predictive Analytics and Computer Visualization Enhances Patient Safety to Prev… | Na | Falls and Falls With Injury | Unknown | 2024-05-01 | 2025-07-01 | ClinicalTrials.gov |
| NCT06223295 | Effectiveness of Focal Therapy in Men With Prostate Cancer | Na | Prostate Cancer | Recruiting | 2024-02-01 | 2031-02-01 | ClinicalTrials.gov |
| NCT06752499 | rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunc… | Na | Stroke | Completed | 2023-02-20 | 2025-09-10 | ClinicalTrials.gov |
| NCT05428839 | The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Pati… | Na | Sleep Apnea, Obstructive | Unknown | 2022-05-11 | 2025-01-31 | ClinicalTrials.gov |
| NCT03827187 | Awareness Detection and Communication in Disorders of Consciousness | Na | Disorder of Consciousness | Recruiting | 2022-02-08 | 2026-08-01 | ClinicalTrials.gov |
| NCT04457154 | Pediatric Post-Approval Registry | — | Obstructive Sleep Apnea | Recruiting | 2021-11-30 | 2028-04-01 | ClinicalTrials.gov |
| NCT04307303 | Electrical Stimulation of Abdominal Muscles for Bowel Management in People With… | Na | Neurogenic Bowel | Completed | 2021-07-07 | 2025-06-11 | ClinicalTrials.gov |
| NCT04900844 | Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stent… | Na | Carotid Artery Stenosis | Active_Not_Recruiting | 2021-07-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT04801771 | Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Synd… | Phase3 | Down Syndrome | Active_Not_Recruiting | 2021-06-24 | 2027-09-30 | ClinicalTrials.gov |
| NCT04885803 | Vitamin D Absorbance Study - Clinical Trial of the Absorbance of Nano Liquid D3 | Na | Vitamin D Deficiency | Completed | 2021-03-26 | 2021-07-30 | ClinicalTrials.gov |
| NCT04937062 | Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy | Early_Phase1 | STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder | Active_Not_Recruiting | 2021-03-01 | 2026-12-31 | ClinicalTrials.gov |
| NCT04416542 | Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization … | Na | Obstructive Sleep Apnea | Completed | 2020-07-28 | 2022-06-10 | ClinicalTrials.gov |
| NCT04768543 | Stimulation Therapy for Apnea: Reporting Thoughts | — | Obstructive Sleep Apnea | Completed | 2020-03-02 | 2021-05-01 | ClinicalTrials.gov |
| NCT04234854 | OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque … | — | Carotid Artery Diseases | Unknown | 2020-01-31 | 2023-03-01 | ClinicalTrials.gov |
| NCT03844295 | Obstructive Sleep Apnea Therapy by Stimulation of the Hypoglossal Nerve | Na | Obstructive Sleep Apnea Syndrome | Completed | 2019-03-21 | 2023-10-10 | ClinicalTrials.gov |
| NCT03668444 | Mobile Support to Improve Recovery and Treatment Court Outcomes | Na | Substance Use | Unknown | 2018-10-01 | 2019-09-30 | ClinicalTrials.gov |
| NCT03592914 | Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patie… | — | Respiratory Insufficiency | Completed | 2018-07-31 | 2019-01-16 | ClinicalTrials.gov |
| NCT03536338 | Spinal Stimulation Sit-to-Stand Training After Spinal Cord Injury | Na | Spinal Cord Injuries | Terminated | 2018-07-24 | 2020-03-23 | ClinicalTrials.gov |
| NCT03152253 | Individually Tailored and Integrated Social Support Network for Tobacco Cessati… | Na | Smoking Cessation | Completed | 2017-05-30 | 2018-11-30 | ClinicalTrials.gov |
| NCT02907398 | Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International R… | — | Obstructive Sleep Apnea | Unknown | 2016-10-19 | 2025-12-01 | ClinicalTrials.gov |
| NCT02715791 | TAPESTRY With Health Connnectors for Diabetes Management | Na | Type 2 Diabetes Mellitus | Completed | 2016-02-01 | 2017-09-26 | ClinicalTrials.gov |
| NCT02222116 | OCT Study of the MGuard Prime Stent in Patients With Heart Attacks | Phase4 | ST Segment Elevated Myocardial Infarction | Withdrawn | 2015-10-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02675816 | Inspire® Upper Airway Stimulation System | Phase4 | Obstructive Sleep Apnea | Terminated | 2015-08-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02413970 | Inspire® Post-Approval Study / Protocol Number 2014-001 | Na | Obstructive Sleep Apnea | Unknown | 2015-05-01 | 2025-06-01 | ClinicalTrials.gov |
| NCT02344108 | A Pilot Study to Evaluate the Hypoglossal Nerve Stimulator in Adolescents With … | Na | Sleep Apnea, Obstructive | Completed | 2015-02-01 | 2021-09-02 | ClinicalTrials.gov |
| NCT02293746 | Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study | Phase4 | Obstructive Sleep Apnea | Completed | 2014-06-01 | 2017-01-09 | ClinicalTrials.gov |
| NCT02292823 | MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myoc… | — | ST Elevation Myocardial Infarction | Terminated | 2014-04-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01869738 | MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation M… | Na | ST Elevation Myocardial Infarction | Terminated | 2013-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01368471 | Safety and Efficacy Study of MGuard Stent After a Heart Attack | Phase4 | Myocardial Infarction | Completed | 2011-06-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01059487 | Bringing Acute and Wellness Care to Underserved Populations Using Traditional C… | Early_Phase1 | Pain Management | Unknown | 2010-09-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01161420 | Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com) | Phase3 | Obstructive Sleep Apnea | Completed | 2010-07-01 | 2017-04-01 | ClinicalTrials.gov |
| NCT00922337 | The Israeli MGuard Registry | — | Ischemic Heart Disease | Completed | 2009-07-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01166464 | Examining a Text Message Intervention for Smoking Cessation | Na | Tobacco Use Disorder | Completed | 2009-07-01 | 2012-10-01 | ClinicalTrials.gov |
Total clinical trials: 42
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Usual Care | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| TAP-HC-DM | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| Usual Care | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| TAP-HC-DM | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| Usual Care | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| TAP-HC-DM | Other | Approved | Type 2 Diabetes Mellitus | COMPLETED | NCT02715791 |
| Traditional Chinese Medicine | Other | Phase EARLY_PHASE1 | Pain Management | UNKNOWN | NCT01059487 |
| Traditional Chinese Medicine | Other | Phase EARLY_PHASE1 | Pain Management | UNKNOWN | NCT01059487 |
| Traditional Chinese Medicine | Other | Phase EARLY_PHASE1 | Pain Management | UNKNOWN | NCT01059487 |
| Control BMS or DES | Other | Phase PHASE4 | Myocardial Infarction | COMPLETED | NCT01368471 |
| MGuard | Other | Phase PHASE4 | Myocardial Infarction | COMPLETED | NCT01368471 |
| Generic text messages | Other | Approved | Tobacco Use Disorder | COMPLETED | NCT01166464 |
| text messaging for smoking cessation | Other | Approved | Tobacco Use Disorder | COMPLETED | NCT01166464 |
| Generic text messages | Other | Approved | Tobacco Use Disorder | COMPLETED | NCT01166464 |
| text messaging for smoking cessation | Other | Approved | Tobacco Use Disorder | COMPLETED | NCT01166464 |
| MGuard Coronary Stent system | Other | Preclinical | Ischemic Heart Disease | COMPLETED | NCT00922337 |
| MGuard Coronary Stent system | Other | Preclinical | Ischemic Heart Disease | COMPLETED | NCT00922337 |
| Control BMS DES | Other | Phase PHASE4 | ST Segment Elevated Myocardial Infarction | WITHDRAWN | NCT02222116 |
| MGuard Prime | Other | Phase PHASE4 | ST Segment Elevated Myocardial Infarction | WITHDRAWN | NCT02222116 |
| MGuard™ Prime Embolic Protection Stent System | Other | Preclinical | ST Elevation Myocardial Infarction | TERMINATED | NCT02292823 |
| MGuard™ Prime Embolic Protection Stent System | Other | Preclinical | ST Elevation Myocardial Infarction | TERMINATED | NCT02292823 |
| (BMS/DES) | Other | Approved | ST Elevation Myocardial Infarction | TERMINATED | NCT01869738 |
| MGuard Prime | Other | Approved | ST Elevation Myocardial Infarction | TERMINATED | NCT01869738 |
| (BMS/DES) | Other | Approved | ST Elevation Myocardial Infarction | TERMINATED | NCT01869738 |
| MGuard Prime | Other | Approved | ST Elevation Myocardial Infarction | TERMINATED | NCT01869738 |
| Inspire® Upper Airway Stimulation (UAS) System | Other | Phase PHASE4 | Obstructive Sleep Apnea | TERMINATED | NCT02675816 |
| Inspire Upper Airway Stimulation System | Other | Phase PHASE3 | Obstructive Sleep Apnea | COMPLETED | NCT01161420 |
| TAU- Treatment As Usual | Drug | Approved | Substance Use | UNKNOWN | NCT03668444 |
| TXS- Supportive Text Group | Other | Approved | Substance Use | UNKNOWN | NCT03668444 |
| TAU- Treatment As Usual | Drug | Approved | Substance Use | UNKNOWN | NCT03668444 |
| TXS- Supportive Text Group | Other | Approved | Substance Use | UNKNOWN | NCT03668444 |
| Motivational Messages | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Peer Support | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Text My Quit (TMQ) | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Motivational Messages | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Peer Support | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Text My Quit (TMQ) | Other | Approved | Smoking Cessation | COMPLETED | NCT03152253 |
| Sit-to-stand Training | Other | Approved | Spinal Cord Injuries | TERMINATED | NCT03536338 |
| Spinal Stimulation | Other | Approved | Spinal Cord Injuries | TERMINATED | NCT03536338 |
| Inspire® Upper Airway Stimulation (UAS) System | Other | Phase PHASE4 | Obstructive Sleep Apnea | COMPLETED | NCT02293746 |
| Placebo Control | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| 25(OH)D Blood Serum Test | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Nano Liquid Vitamin D3 | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Softgel Vitamin D3 | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Placebo Control | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| 25(OH)D Blood Serum Test | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Nano Liquid Vitamin D3 | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Softgel Vitamin D3 | Other | Approved | Vitamin D Deficiency | COMPLETED | NCT04885803 |
| Intravascular Utrasound (IVUS) of Carotid Artery after implantation of CGuard stent | Other | Preclinical | Carotid Artery Diseases | UNKNOWN | NCT04234854 |
| Intravascular Utrasound (IVUS) of Carotid Artery after implantation of CGuard stent | Other | Preclinical | Carotid Artery Diseases | UNKNOWN | NCT04234854 |
| Intravascular Utrasound (IVUS) of Carotid Artery after implantation of CGuard stent | Other | Preclinical | Carotid Artery Diseases | UNKNOWN | NCT04234854 |
| Inspire® Upper Airway Simulation System (Model 3028 IPG ) | Other | Approved | Sleep Apnea, Obstructive | COMPLETED | NCT02344108 |
| Home Sleep Testing | Other | Approved | Obstructive Sleep Apnea | COMPLETED | NCT04416542 |
| Upper airway stimulation (Inspire Medical Systems, Inc.) | Other | Preclinical | Obstructive Sleep Apnea | COMPLETED | NCT04768543 |
| Usual care | Other | Approved | Prostate Cancer | RECRUITING | NCT06223295 |
| Focal therapy | Drug | Approved | Prostate Cancer | RECRUITING | NCT06223295 |
| Usual care | Other | Approved | Prostate Cancer | RECRUITING | NCT06223295 |
| Focal therapy | Drug | Approved | Prostate Cancer | RECRUITING | NCT06223295 |
| Inspiren camera visualization | Other | Approved | Falls and Falls With Injury | UNKNOWN | NCT06339125 |
| Fall prevention algorithm | Other | Approved | Falls and Falls With Injury | UNKNOWN | NCT06339125 |
| Inspiren camera visualization | Other | Approved | Falls and Falls With Injury | UNKNOWN | NCT06339125 |
| Fall prevention algorithm | Other | Approved | Falls and Falls With Injury | UNKNOWN | NCT06339125 |
| Inactivated Inspire® Upper Airway Stimulation System | Other | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT03844295 |
| Activated Inspire® Upper Airway Stimulation System | Other | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT03844295 |
| Inspire System | Other | Approved | Obstructive Sleep Apnea | RECRUITING | NCT06540716 |
| Pharyngeal width measurement | Other | Approved | Sleep Apnea, Obstructive | UNKNOWN | NCT05428839 |
| Motor imagery based EEG-BCI | Other | Approved | Disorder of Consciousness | RECRUITING | NCT03827187 |
| Motor imagery based EEG-BCI | Other | Approved | Disorder of Consciousness | RECRUITING | NCT03827187 |
| Inspire® UAS System | Other | Approved | Obstructive Sleep Apnea | UNKNOWN | NCT02413970 |
| Inspire Upper Airway Stimulation System | Other | Preclinical | Obstructive Sleep Apnea | RECRUITING | NCT04457154 |
| Hypoglossal Nerve Stimulation | Other | Approved | Pediatric Obstructive Sleep Apnea | RECRUITING | NCT06851338 |
| CGuard Carotid Stent implantation | Other | Approved | Carotid Artery Stenosis | ACTIVE_NOT_RECRUITING | NCT04900844 |
| CGuard Carotid Stent implantation | Other | Approved | Carotid Artery Stenosis | ACTIVE_NOT_RECRUITING | NCT04900844 |
| CGuard Carotid Stent implantation | Other | Approved | Carotid Artery Stenosis | ACTIVE_NOT_RECRUITING | NCT04900844 |
| CGuard Prime 80cm stent system | Other | Approved | Carotid Artery Diseases | RECRUITING | NCT06653387 |
| CGuard Prime 80cm stent system | Other | Approved | Carotid Artery Diseases | RECRUITING | NCT06653387 |
| No intervention | Other | Preclinical | Obstructive Sleep Apnea | UNKNOWN | NCT02907398 |
| Inspire therapy | Drug | Preclinical | Obstructive Sleep Apnea | UNKNOWN | NCT02907398 |
| Inspire UAS System | Other | Preclinical | Obstructive Sleep Apnea | RECRUITING | NCT06971796 |
| Inspire Upper Airway Stimulation (UAS) System | Other | Phase PHASE3 | Down Syndrome | ACTIVE_NOT_RECRUITING | NCT04801771 |
| Sham stimulation | Other | Approved | Stroke | RECRUITING | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | RECRUITING | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | RECRUITING | NCT06752499 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Tranexamic Acid (TXA) | Other | Phase PHASE4 | Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System | NOT_YET_RECRUITING | NCT07116395 |
| abdominal functional electrical stimulation | Other | Approved | Neurogenic Bowel | COMPLETED | NCT04307303 |
| SwitchGuardTM NPS | Other | Approved | Carotid Artery Stenosis | NOT_YET_RECRUITING | NCT07277296 |
| SwitchGuardTM NPS | Other | Approved | Carotid Artery Stenosis | NOT_YET_RECRUITING | NCT07277296 |
| glUCModel app | Other | Approved | Diabetes (Insulin-requiring, Type 1 or Type 2) | RECRUITING | NCT07304778 |
| glUCModel app | Other | Approved | Diabetes (Insulin-requiring, Type 1 or Type 2) | RECRUITING | NCT07304778 |
| Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] | Other | Phase EARLY_PHASE1 | STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder | ACTIVE_NOT_RECRUITING | NCT04937062 |
| Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] | Other | Phase EARLY_PHASE1 | STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder | ACTIVE_NOT_RECRUITING | NCT04937062 |
| Financial Incentive and Text-Messages | Other | Phase EARLY_PHASE1 | First-Episode Psychosis | ACTIVE_NOT_RECRUITING | NCT05967195 |
| Inspire® UAS System | Other | Preclinical | Obstructive Sleep Apnea (OSA) | RECRUITING | NCT07113288 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Sham stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Offline stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| Online stimulation | Other | Approved | Stroke | COMPLETED | NCT06752499 |
| SwitchGuardTM NPS | DEVICE | Approved | Carotid Artery Stenosis | NOT_YET_RECRUITING | NCT07277296 |
| Inspire UAS System | DEVICE | Preclinical | Obstructive Sleep Apnea | RECRUITING | NCT06971796 |
| Hypoglossal Nerve Stimulation | DEVICE | Approved | Pediatric Obstructive Sleep Apnea | RECRUITING | NCT06851338 |
| CGuard Prime 80cm stent system | DEVICE | Approved | Carotid Artery Diseases | RECRUITING | NCT06653387 |
| Inspire System | DEVICE | Approved | Obstructive Sleep Apnea | RECRUITING | NCT06540716 |
| Inspiren camera visualization | OTHER | Approved | Falls and Falls With Injury | NOT_YET_RECRUITING | NCT06339125 |
| Fall prevention algorithm | OTHER | Approved | Falls and Falls With Injury | NOT_YET_RECRUITING | NCT06339125 |
| Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] | DRUG | Phase EARLY_PHASE1 | STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder | ACTIVE_NOT_RECRUITING | NCT04937062 |
| CGuard Carotid Stent implantation | DEVICE | Approved | Carotid Artery Stenosis | ACTIVE_NOT_RECRUITING | NCT04900844 |
| Inspire Upper Airway Stimulation (UAS) System | DEVICE | Phase PHASE3 | Down Syndrome | ACTIVE_NOT_RECRUITING | NCT04801771 |
| Upper airway stimulation (Inspire Medical Systems, Inc.) | DEVICE | Preclinical | Obstructive Sleep Apnea | COMPLETED | NCT04768543 |
| Inactivated Inspire® Upper Airway Stimulation System | DEVICE | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT03844295 |
| Activated Inspire® Upper Airway Stimulation System | DEVICE | Approved | Obstructive Sleep Apnea Syndrome | COMPLETED | NCT03844295 |
| No intervention | OTHER | Preclinical | Obstructive Sleep Apnea | ACTIVE_NOT_RECRUITING | NCT02907398 |
| Inspire therapy | DEVICE | Preclinical | Obstructive Sleep Apnea | ACTIVE_NOT_RECRUITING | NCT02907398 |
| Inspire® UAS System | DEVICE | Preclinical | Obstructive Sleep Apnea (OSA) | RECRUITING | NCT07113288 |
| Inspire® Upper Airway Simulation System (Model 3028 IPG ) | DEVICE | Approved | Sleep Apnea, Obstructive | COMPLETED | NCT02344108 |
| Inspire® Upper Airway Stimulation (UAS) System | DEVICE | Phase PHASE4 | Obstructive Sleep Apnea | TERMINATED | NCT02675816 |
| MGuard™ Prime Embolic Protection Stent System | DEVICE | Preclinical | ST Elevation Myocardial Infarction | TERMINATED | NCT02292823 |
| Control BMS DES | DEVICE | Phase PHASE4 | ST Segment Elevated Myocardial Infarction | WITHDRAWN | NCT02222116 |
| (BMS/DES) | DEVICE | Approved | ST Elevation Myocardial Infarction | TERMINATED | NCT01869738 |
| MGuard Prime | DEVICE | Phase PHASE4 | ST Segment Elevated Myocardial Infarction | WITHDRAWN | NCT02222116 |
| Control BMS or DES | DEVICE | Phase PHASE4 | Myocardial Infarction | COMPLETED | NCT01368471 |
| MGuard | DEVICE | Phase PHASE4 | Myocardial Infarction | COMPLETED | NCT01368471 |
| MGuard Coronary Stent system | DEVICE | Preclinical | Ischemic Heart Disease | COMPLETED | NCT00922337 |
| Inspire Upper Airway Stimulation System | DEVICE | Preclinical | Obstructive Sleep Apnea | RECRUITING | NCT04457154 |
Total products: 147